BRCA1/2-话题@MedSci

#BRCA1/2#

30篇内容 | 2927人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1518979, encodeId=4f3c15189e945, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=Brit J Cancer：IVF卵巢刺激与BRCA1/2突变携带者原发性乳腺癌风险！, objectType=article, longId=141707, objectId=f022141e0757, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f022141e0757, replyNumber=0, likeNumber=90, createdTime=2018-06-28, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f022141e0757, moduleTitle=Brit J Cancer：IVF卵巢刺激与BRCA1/2突变携带者原发性乳腺癌风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f022141e0757)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518978, encodeId=0dd215189e893, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=Nat Med：“靶向化疗”成为可能—卡铂用于治疗BRCA1/2突变及BRCAness表型三阴性乳腺癌的III期TNT研究, objectType=article, longId=137196, objectId=7db713e1967a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7db713e1967a, replyNumber=0, likeNumber=104, createdTime=2018-05-05, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7db713e1967a, moduleTitle=Nat Med：“靶向化疗”成为可能—卡铂用于治疗BRCA1/2突变及BRCAness表型三阴性乳腺癌的III期TNT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7db713e1967a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518977, encodeId=265615189e7e7, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=ANN ONCOL：局部复发或转移性BRCA1/2乳腺癌患者治疗方案比较, objectType=article, longId=127478, objectId=90d712e4782d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90d712e4782d, replyNumber=0, likeNumber=82, createdTime=2018-01-25, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90d712e4782d, moduleTitle=ANN ONCOL：局部复发或转移性BRCA1/2乳腺癌患者治疗方案比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90d712e4782d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518976, encodeId=98b815189e696, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=Lancet Oncol：奥拉帕尼片剂可用于铂敏感、复发性卵巢癌及BRCA1/2突变(SOLO2/ENGOT-Ov21/)患者的维持治疗, objectType=article, longId=106877, objectId=eba21068e7a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eba21068e7a6, replyNumber=0, likeNumber=91, createdTime=2017-07-28, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eba21068e7a6, moduleTitle=Lancet Oncol：奥拉帕尼片剂可用于铂敏感、复发性卵巢癌及BRCA1/2突变(SOLO2/ENGOT-Ov21/)患者的维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eba21068e7a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518975, encodeId=667a15189e583, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=JAMA Oncol.:BRCA1/2基因突变状态能否预测三阴乳腺癌新辅助化疗效果？, objectType=article, longId=105944, objectId=e78710594471, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e78710594471, replyNumber=0, likeNumber=98, createdTime=2017-07-20, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e78710594471, moduleTitle=JAMA Oncol.:BRCA1/2基因突变状态能否预测三阴乳腺癌新辅助化疗效果？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e78710594471)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518974, encodeId=ce4715189e477, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=JAMA:BRCA1/2突变携带者，不同年龄阶段的患癌风险到底有多大？, objectType=article, longId=103121, objectId=6c24103121f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c24103121f0, replyNumber=0, likeNumber=69, createdTime=2017-06-25, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c24103121f0, moduleTitle=JAMA:BRCA1/2突变携带者，不同年龄阶段的患癌风险到底有多大？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c24103121f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518973, encodeId=9cc115189e3bf, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=ASCO2017:从临床组织和液体活检样本中发现了前列腺癌的BRCA1/2基因回复突变, objectType=article, longId=100929, objectId=567b1009293e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=567b1009293e, replyNumber=0, likeNumber=89, createdTime=2017-06-08, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=567b1009293e, moduleTitle=ASCO2017:从临床组织和液体活检样本中发现了前列腺癌的BRCA1/2基因回复突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=567b1009293e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518972, encodeId=9b7815189e2ee, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=Breast Cancer Res Treat：中国乳腺癌女性BRCA1/2突变研究, objectType=article, longId=73659, objectId=41cfe365904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41cfe365904, replyNumber=0, likeNumber=86, createdTime=2016-07-26, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41cfe365904, moduleTitle=Breast Cancer Res Treat：中国乳腺癌女性BRCA1/2突变研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41cfe365904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518971, encodeId=accb15189e183, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=Nature：解密明星抑癌基因BRCA1/2, objectType=article, longId=34510, objectId=1ba5345103d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ba5345103d, replyNumber=0, likeNumber=87, createdTime=2014-05-11, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ba5345103d, moduleTitle=Nature：解密明星抑癌基因BRCA1/2, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ba5345103d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518970, encodeId=3bb215189e07c, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=JCO:口服避孕药不降低BRCA1/2突变携带者的卵巢癌及乳腺癌风险, objectType=article, longId=26026, objectId=cd98260269f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd98260269f, replyNumber=0, likeNumber=118, createdTime=2013-11-02, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd98260269f, moduleTitle=JCO:口服避孕药不降低BRCA1/2突变携带者的卵巢癌及乳腺癌风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd98260269f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518969, encodeId=9600151896989, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=Cancer Cell：FA基因与RAD51-BRCA1/2联合保护DNA复制叉，抑制肿瘤发生, objectType=article, longId=7871, objectId=5a9de8719e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a9de8719e, replyNumber=0, likeNumber=0, createdTime=2012-07-18, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a9de8719e, moduleTitle=Cancer Cell：FA基因与RAD51-BRCA1/2联合保护DNA复制叉，抑制肿瘤发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a9de8719e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1518968, encodeId=464b15189680f, content=<a href='/topic/show?id=da4e368832' target=_blank style='color:#2F92EE;'>#BRCA1/2#</a>, objectTitle=JCO：卵巢癌生殖系BRCA1/2测试, objectType=article, longId=7266, objectId=5fd7e26682, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fd7e26682, replyNumber=0, likeNumber=102, createdTime=2012-06-22, rootId=0, userName=fangcong, userId=63ce11226326, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fd7e26682, moduleTitle=JCO：卵巢癌生殖系BRCA1/2测试, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fd7e26682)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

BRCA1/2

2020-05-29

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

Brit J Cancer：IVF卵巢刺激与BRCA1/2突变携带者原发性乳腺癌风险！

2018-06-28

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

Nat Med：“靶向化疗”成为可能—卡铂用于治疗BRCA1/2突变及BRCAness表型三阴性乳腺癌的III期TNT研究

2018-05-05

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

ANN ONCOL：局部复发或转移性BRCA1/2乳腺癌患者治疗方案比较

2018-01-25

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

Lancet Oncol：奥拉帕尼片剂可用于铂敏感、复发性卵巢癌及BRCA1/2突变(SOLO2/ENGOT-Ov21/)患者的维持治疗

2017-07-28

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

JAMA Oncol.:BRCA1/2基因突变状态能否预测三阴乳腺癌新辅助化疗效果？

2017-07-20

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

JAMA:BRCA1/2突变携带者，不同年龄阶段的患癌风险到底有多大？

2017-06-25

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

ASCO2017:从临床组织和液体活检样本中发现了前列腺癌的BRCA1/2基因回复突变

2017-06-08

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

Breast Cancer Res Treat：中国乳腺癌女性BRCA1/2突变研究

2016-07-26

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

Nature：解密明星抑癌基因BRCA1/2

2014-05-11

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

JCO:口服避孕药不降低BRCA1/2突变携带者的卵巢癌及乳腺癌风险

2013-11-02

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

Cancer Cell：FA基因与RAD51-BRCA1/2联合保护DNA复制叉，抑制肿瘤发生

2012-07-18

fangcong (审核中...)

前往app查看评论内容

#BRCA1/2#

JCO：卵巢癌生殖系BRCA1/2测试

2012-06-22

科室
- - 订阅+
  - 更多科室
工具
服务